ClinicalTrials.gov
public full text
Public Domain
Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia
Fibrous dysplasia is a rare bone disease which can cause pain and fractures. It has been shown that periostin is over expressed in fibrous component in patients bones ; but periostin has never been measured out in serum of patients, although it is easy to assess. This study aims to show whether serum periostin is elevated in serum of patients with fibrous dysplasia, and if it is more elevated in patients with severe forms of the disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)#899339
- Characterisation of Uterine Fibroid Tissue Stiffness#980049
- DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA#1293907
- Calorie restriction leads to degradation of mutant uromodulin and ameliorates inflammation and fibrosis in <i>UMOD</i> -related kidney disease#307813
- Contribution of Bone to Urine Citrate#885214
Record · ID 1182963
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive